Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationBiomedicines
View this publicationFrontiers in immunology
View this publicationBiology
View this publicationInternational journal of molecular sciences
View this publicationSkeletal radiology
View this publicationJournal of neuroinflammation
View this publicationCells
View this publicationInternational journal of molecular sciences
View this publicationFrontiers in immunology
View this publication